SEQUENOM, Inc. (NASDAQ: SQNM) announced that the expected launch of its SEQureDx Down syndrome test is delayed, due to the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE